US Patent

US9539241 — Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application

Method of Use · Assigned to Mobius Therapeutics LLC · Expires 2028-01-02 · 2y remaining

Vulnerability score 58/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an apparatus and method for reconstituting a pharmaceutical, specifically an ophthalmic formulation of mitomycin-C, for transient application.

USPTO Abstract

An apparatus and method for preparing a pharmaceutical for transient application includes a tray having a sealed compartment, a vial of an ophthalmic formulation of mitomycin-C, a diluent carrier containing sterilized water, and a syringe that are all contained together in a single package. The component parts of the apparatus are used together to reconstitute the contents of the vial with the water in the diluent carrier, and then draw the reconstituted drug into the sealed compartment of the tray by a suction force produced by the syringe. In the tray compartment, the reconstituted drug is absorbed in at least one absorbent pad. The absorbent pads may come in multiple shapes and or/sizes. The tray is opened to remove the pad and the absorbed drug from the tray compartment for use of the pad in transient application of the drug.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-2095 — Mitozytrex

Patent Metadata

Patent number
US9539241
Jurisdiction
US
Classification
Method of Use
Expires
2028-01-02
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Mobius Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.